Thalidomide in patients with advanced multiple myeloma.
Yakoub-Agha I, Moreau P, Leyvraz S, Berthou C, Payen C, Dumontet C, Grosbois B, Beris P, Duguet C, Attal M, Harousseau JL, Facon T; Intergroupe Francophone du Myélome (IFM).
Yakoub-Agha I, et al. Among authors: facon t.
Hematol J. 2000;1(3):186-9. doi: 10.1038/sj.thj.6200031.
Hematol J. 2000.
PMID: 11920188
Clinical Trial.